ArticleBMC rheumatology2025

Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling.

Bui Hai Binh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.